Tumor heterogeneity and resistance to EGFR-targeted therapy in advanced nonsmall cell lung cancer: challenges and perspectives
Xinghua Cheng, Haiquan ChenDepartment of Thoracic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of ChinaAbstract: Lung cancer, mostly nonsmall cell lung cancer, continues to be the leading cause of cancer-related death worldwide. With the development of tyr...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2014-09-01
|
| Series: | OncoTargets and Therapy |
| Online Access: | http://www.dovepress.com/tumor-heterogeneity-and-resistance-to-egfr-targeted-therapy-in-advance-peer-reviewed-article-OTT |